You are here

Articles

CHMP positive recommendation for use of Tasigna in Newly Diagnosed Ph+ CML

published: 25 September 2010

Changing the Culture of Clinical Trials: Reviving a Failing Effort

published: 22 September 2010

NEJM article: “Liberating the NHS” — Another Attempt to Implement Market Forces in English Health Care

published: 22 September 2010

New BCR/Abl Inhibitor from Ariad Pharmaceuticals

published: 21 September 2010

Blood Journal-Long-term prognostic significance of early molecular response to imatinib

published: 25 August 2010

Haematology Times- EHA role of Patient Advocacy

published: 26 July 2010

Discovery suggests possible treatment strategy for aggressive leukemias

published: 20 July 2010

Tasigna Beats Sprycel to First-Line CML Punch

published: 12 July 2010

Bosutinib Induces High Response Rates in Imatinib-Resistant, -Intolerant Patients

published: 28 June 2010

Making Expanded Access Programs Work For –Not Against– Your Trial Drug

published: 8 June 2010

New England Journal - Editorial

published: 8 June 2010

Impact of JAK2V617F-mutation status, allele burden and clearance after allogeneic stem cell transplantation for myelofibrosis

published: 8 June 2010

TKI Therapy and depression

published: 3 June 2010

mmm! this is an interesting hypothesis. Tyrosine kinase inhibitor therapy can cure chronic myeloid leukemia without hitting leukemic stem cells

published: 2 June 2010

ASCO 2010- Abstracts from the yearly meeting of the American Society of Clinical Oncology

published: 28 May 2010

Functional Activity of the OCT-1 Protein Is Predictive of Long-Term Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib J Clin Oncol. 2010 Apr 26;

published: 18 May 2010

WT1 PEPTIDE VACCINATION IN COMBINATION WITH IMATINIB THERAPY FOR A PATIENT WITH CML IN THE CHRONIC PHASE

published: 5 May 2010

MDACC: Leukaemia Insights

published: 22 April 2010

Welcome to CMLSupport.org.uk - please sign our petition!

published: 5 April 2010

FDA- rules against targeted therapy because 'standarized' mutation test is not available.

published: 28 March 2010